...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of endometriosis and pelvic pain disorders. >Evaluation of dienogest treatment efficacy in patients with endometriosis
【24h】

Evaluation of dienogest treatment efficacy in patients with endometriosis

机译：对dienogest治疗疗效的评价子宫内膜异位症患者

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: The aim of the study was to evaluate the efficacy and safety of postoperative dienogest treatment in endometriosis patients.Materials and methods: A total of 53 patients suffering from endometriosis were enrolled. All participants underwent laparoscopic operative treatment. Afterwards, all patients were divided into 2 groups: Group 1 (control group) and Group 2 (receiving dienogest 2 mg/day after surgery). Comparative analysis was performed evaluating patients' condition and complaints in the postoperative period, the disease dynamics at 3 and 6 months after the surgery, pain assessment (visual analogue scale) and severity of metrorrhagia in both groups. Results: Postoperative dienogest treatment reduces the severity of symptoms and improves treatment outcomes in endometriosis patients, leading to the improvement of the quality of life in these patients. Conclusions: Dienogest (2 mg/day) is a highly effective drug for postoperative treatment of patients with endometriosis. Dienogest (2 mg/day) significantly decreases the severity of pelvic pain and metrorrhagia after surgery. The medication is safe and side effects are rare.
机译：背景:该研究的目的是评估术后的疗效和安全性dienogest治疗子宫内膜异位病人。患有子宫内膜异位症登记。手术治疗。被分为2组:第1组(控制组)和组2(接收dienogest 2毫克/天手术后)。评估病人的条件和执行投诉在术后期间,疾病动态3和6个月后手术疼痛评估(视觉模拟量表)并在两组子宫出血的严重程度。结果:术后dienogest治疗减少症状的严重程度,改善子宫内膜异位症患者的治疗结果,导致生活质量的改善在这些病人。毫克/天)是一种高效的药物术后治疗的患者子宫内膜异位症。减少骨盆疼痛的严重程度手术后子宫出血。安全,副作用是罕见的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号